Simplify Logo

Full-Time

Executive Director

Clinical Development

Confirmed live in the last 24 hours

Generate Biomedicines

Generate Biomedicines

51-200 employees

Generates novel medicines using machine learning

Hardware
AI & Machine Learning
Biotechnology
Healthcare

Senior, Expert

United States

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Communications
Requirements
  • Ph.D. and/or M.D. with biopharmaceutical industry experience of 15+ years in leading clinical development for early- and mid-stage therapeutic programs.
  • Demonstrated leadership, organization, and excellent written and verbal communication skills.
  • Ability to work collaboratively in a fast-paced, team-based matrix environment.
  • Demonstrated record of designing, planning and executing clinical studies.
  • Demonstrated record of strategic development planning, leadership and decision-making resulting in successful outcomes.
  • Elevated interpersonal and communication skills with ability to flexibly relate to both internal and external stakeholders. Ability to develop strong collaborative relationships with colleagues across all functional areas.
  • Experience providing leadership and guidance to project teams.
  • Ability to thrive in a fast-paced, innovative environment while remaining flexible, proactive, resourceful and getting work done efficiently.
  • A proactive ability to analyze complex issues to develop relevant and realistic plans, programs and recommendations.
  • Attention to detail and quality while also being aware of the need to make timely decisions and to execute.
  • Growth/ (or innovative) mindset and desire to work in a fast-paced dynamic environment and collaborate openly with others.
  • Proven excellence in development and leadership of a cross-functional clinical program team.
  • Patient-first attitude in trial design and execution.
Responsibilities
  • Accountable for clinical development plans and overall clinical strategy; serve as program lead in internal and external interactions, championing programs and positioning them for success.
  • Contribute to development of protocols and other critical study documents (Statistical Analysis Plans, Investigator Brochures, IND submissions, Clinical Study Reports, etc.).
  • Facilitate the conduct of clinical trials by: Developing and maintaining excellent working relationships with investigators; Delivering high quality scientific presentations on company technology, investigational agents and/or clinical study issues to investigators and clinical site staff; Providing guidance and/or training for external personnel/parties involved in company clinical studies to ensure subject safety and adherence to the protocol and good clinical practice (GCP).
  • Identify emerging risks and manage them with the team as appropriate.
  • Mentor the project team, including any clinical scientists and project team leaders directly or indirectly reporting to this position, and provide clinical education support for internal company customers.
  • Interpret clinical data and author clinical study reports (CSR).
  • Lead clinical strategy for regulatory submissions, responses to regulatory questions and presentations at regulatory meetings.
  • Interact with regulatory agencies, in concert with the Regulatory Affairs Department, to develop novel and efficient clinical programs in both rare and common disease populations.
  • Establish external medical/scientific advisory teams and interact with thought leaders and clinical investigators in the therapeutic area to prepare/revise/maintain and efficiently execute the drug development plan.
  • Support publication strategy of clinical data through preparation and submission of clinical findings to scientific journals and conferences.
  • Maintain clinical and technical expertise in the therapeutic area; review scientific journals, attend scientific and key technical meetings and partner with company medical, research and commercial teams.
  • Assist in accomplishing department and corporate objectives.
Generate Biomedicines

Generate Biomedicines

View

Generate Biomedicines focuses on creating new medicines using a method called generative biology, which combines machine learning and biological engineering. This approach involves analyzing millions of proteins to learn how nature encodes their functions, allowing the company to design new medicines with specific therapeutic effects. The main product, The Generate Platform, enables the rapid production of medicines across various therapeutic areas, significantly improving the drug discovery process compared to traditional methods. Unlike its competitors, Generate Biomedicines emphasizes a proactive and efficient approach to medicine creation, aiming to democratize access to biotherapeutics. The company's goal is to expand its capabilities in generating and testing proteins, having already produced 42,000 proteins, and to continue advancing the field of therapeutics.

Company Stage

Series C

Total Funding

$693M

Headquarters

Somerville, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

5%

1 year growth

15%

2 year growth

44%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $273M Series C financing round provides substantial capital to advance their generative AI pipeline and clinical programs.
  • Expansion of the leadership team with experienced professionals like Rupert Vessey, Nancy Simonian, and Kym White strengthens the company's strategic direction and operational capabilities.
  • Publication of the Chroma model in Nature highlights the company's innovative contributions to protein therapeutics, enhancing its reputation in the scientific community.

What critics are saying

  • The reliance on cutting-edge generative AI and machine learning technologies may face regulatory and adoption challenges in the conservative pharmaceutical industry.
  • Rapid expansion and scaling efforts, including new hires and leadership changes, could lead to integration and cultural challenges.

What makes Generate Biomedicines unique

  • Generate Biomedicines leverages generative biology and machine learning to create medicines on demand, a significant departure from traditional drug discovery methods.
  • The Generate Platform's ability to produce novel medicines across multiple therapeutic areas with high speed and success rates sets it apart from competitors.
  • Their focus on understanding the rules by which nature encodes function to design new proteins is a unique approach in the biotechnology sector.